We have received your feedback.Thank you for taking your time in view of your busy schedule.

Weekly News | Amount |
---|---|
Total
|
${lastRankDetail.pages.length} |
Financing | ${lastRankDetail.financing_pages.length} |
Product | ${lastRankDetail.product_pages.length} |
Negative | ${lastRankDetail.sentiment_pages.length} |
Broncus Broncus Bio is a precise interventional therapy technology company for lung diseases. The mission of the company is to provide navigation, diagnosis and treatment technology to treat patients with lung diseases. The company focuses on accurate minimally invasive interventional diagnosis and treatment products for lung diseases such as lung cancer and chronic obstructive pulmonary disease, and makes subversive changes to the diagnosis and treatment mode of lung diseases, improving the survival rate of patients with lung diseases, shortening the diagnosis and treatment cycle and saving medical resources
Transactions
Research
Competition
Transactions
Funding
1 Fundings
Date | Amount | Round | Relative News |
---|---|---|---|
Sep 2020 | Tens of millions USD | Series C | Starting | Broncus C round of financing tens of millions of dollars, continue to lead the field of accurate interventional therapy for lung diseases |
Signals
Events
${currentEventsPage.count} Events
Events (${currentEventsPage.count}) | Date |
---|---|
Nothing Happens :-( | |
${e.desp} | ${e.date} |
News
${ rankDetail.pages.length } News Articles
${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) | Tag |
---|---|
${article.en_title} | ${article.tag} |
Industry Financing Info
Research
Intelligence
0 Research Briefs
Competition
Competitors
0 Competitors